Codexis (CDXS) Revenue Growth (3y) (2013 - 2026)
Codexis (CDXS) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 10.17% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.76% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 77.85% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -25.02% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 42.02% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 59.40% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -37.68% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 76.62% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 7.80% |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 43.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.95% |
| Mar 31, 2026 | 5.51% |
| Dec 31, 2025 | 25.26% |
| Sep 30, 2025 | -37.04% |
| Jun 30, 2025 | -26.37% |
| Mar 31, 2025 | -40.24% |
| Dec 31, 2024 | -4.32% |
| Sep 30, 2024 | -29.59% |
| Jun 30, 2024 | -32.07% |
| Mar 31, 2024 | -1.81% |
| Dec 31, 2023 | -38.05% |
| Sep 30, 2023 | -20.39% |
| Jun 30, 2023 | -30.61% |
| Mar 31, 2023 | -3.99% |
| Dec 31, 2022 | 2.01% |
| Sep 30, 2022 | 16.31% |
| Jun 30, 2022 | 46.09% |
| Mar 31, 2022 | 31.38% |
| Dec 31, 2021 | 15.10% |
| Sep 30, 2021 | 29.46% |